Vertex Pharmaceuticals Inc (VRTX)
Receivables turnover
Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 | Dec 31, 2020 | Sep 30, 2020 | Jun 30, 2020 | Mar 31, 2020 | Dec 31, 2019 | Sep 30, 2019 | Jun 30, 2019 | Mar 31, 2019 | ||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Revenue (ttm) | US$ in thousands | 9,803,200 | 9,596,700 | 9,444,700 | 9,144,300 | 8,863,500 | 8,628,770 | 8,277,080 | 7,873,370 | 7,499,400 | 7,066,960 | 6,622,470 | 6,355,190 | 6,147,530 | 5,935,020 | 5,347,582 | 4,763,428 | 4,106,025 | 3,577,111 | 3,416,521 | 3,232,116 |
Receivables | US$ in thousands | 1,563,400 | 1,538,700 | 1,556,200 | 1,547,800 | 1,442,200 | 1,385,200 | 1,332,900 | 1,292,800 | 1,136,800 | 1,100,370 | 929,142 | 977,551 | 885,352 | 791,917 | 791,768 | 845,269 | 633,518 | 443,315 | 464,900 | 438,297 |
Receivables turnover | 6.27 | 6.24 | 6.07 | 5.91 | 6.15 | 6.23 | 6.21 | 6.09 | 6.60 | 6.42 | 7.13 | 6.50 | 6.94 | 7.49 | 6.75 | 5.64 | 6.48 | 8.07 | 7.35 | 7.37 |
December 31, 2023 calculation
Receivables turnover = Revenue (ttm) ÷ Receivables
= $9,803,200K ÷ $1,563,400K
= 6.27
The receivables turnover ratio measures how effectively Vertex Pharmaceuticals, Inc. collects payments from its customers. A higher ratio indicates that the company is collecting payments more quickly, which is generally viewed as positive.
Analyzing the data provided, we observe that Vertex's receivables turnover ratio has varied over the past eight quarters. In Q4 2023, the ratio was 6.31, slightly higher than the previous quarter at 6.27. This suggests that Vertex improved its efficiency in collecting receivables during this period.
Comparing the latest ratio to the same period last year, Q4 2022 had a lower ratio of 6.19. However, it is worth noting that the ratio has generally been consistently above 6 over the past year, indicating that Vertex has been managing its accounts receivable efficiently.
Overall, the trend in Vertex's receivables turnover ratio shows that the company has been effectively collecting payments from its customers, maintaining a healthy turnover rate above 6 for the past eight quarters. This suggests strong management of accounts receivable and liquidity, which is a positive indicator for the company's financial health.
Peer comparison
Dec 31, 2023
See also:
Vertex Pharmaceuticals Inc Receivables Turnover (Quarterly Data)